Welcome to the PEPITES web site
PEPITES is present at the 58th Annual Conference of Particle Therapy Co-Operative Group in Manchester (UK)
PEPITES brings together researchers, engineers, and technicians, members of Laboratoire Leprince-Ringuet (LLR, CRNS/IN2P3-Ecole polytechnique, UMR7638), of ARRONAX cyclotron (Accélérateur pour la Recherche en Radiochimie et Oncologie à Nantes Atlantique) and of CEA/IRFU (DEDIP/STREAM).
The project aims at developing ultra-thin monitors for charged particles beams.
Originally developed for protontherapy, this type of monitor could fit a multitude of charged particle beams
A patent of the proposed technology has been filed.
Christophe Thiebaux, on behalf of PEPITES consortium, presents a poster at the 58th Annual Conference of the Proton Therapy Co-Operative Group. Find the abstract on the conference website as well as the poster. The poster can also be seen in the Publication section of this website.
PEPITES will participate (poster session) to the “58ème Journées Scientifiques de la SFPM” (2019 June 5-7, Angers, France) The poster can be seen in the Publication section of this website.
Charbel Koumeir, on behalf of PEPITES consortium, presented a poster at the 13th European Conference on Accelerators in Applied Research and Technology (May 5-10, Split, Croatia). Have a look at the poster on the Publication section on our website.
The PEPITES project aims at realizing a fully working ultra-thin monitor prototype able to permanently operate on mid-energy (O(100 MeV)) charged particle accelerators. The targeted beam intensity ranges from a fraction of pA to about 10 nA. The active part of the prototype is built using thin film techniques and a low noise electronic provides the readout. The system itself is very simple to operate, has a small footprint and is expected to be more tolerant to cumulated doses than existing competing devices. The thinness of the materials employed makes it also less prone to heating from beam interaction. The development was initially motivated by the proton therapy needs, but the large flexibility of the techniques employed opens a range of applications that goes well beyond the medical needs. If particularly adapted in the energy and intensity ranges mentioned, the approach is not limited to these, being applicable well above the higher energy and intensity bounds indicated.
The ARRONAX center has expressed its interest for a 10 μm water-equivalent system to be operated for proton, deuteron and alpha beams in energy ranges 17-70 MeV, 8-17 MeV/u and 17 MeV/u for protons, deuterons and alphas, respectively, in the foreseen intensity range. Achieving a working prototype responding to these constraints would demonstrate the viability of the approach.
The project will proceed in four main stages. The signal generation will be studied with a simple set-up in the targeted energy ranges and in the medical one, up to 230 MeV, as existing measurements are quite scarce. The radiations hardness of the active part -its individual components and their assembly- will be studied to optimize the material choice and construction techniques and to additionally anticipate the operation time that a future system could tolerate. This will be conducted under a uniform protocol to allow direct comparison of merits. A dedicated low-noise electronic will be designed and realized. It will provide the readout for operations over about 5 orders of beam current magnitude. The final system performances will be studied in real operation conditions with proton, deuteron, and alpha beams.
Within the framework of the ANR call “appel à projet générique 2017”, PEPITES has formed a consortium led by LLR with teams from ARRONAX and IRFU.
Meet the PEPITES project members.
Use the form below to contact us